Categories
- Administrative law (3,493)
- Admiralty-Maritime Law (2,514)
- Advertising Law (2,069)
- Antitrust – Competition law (735)
- Aviation Law (959)
- Banking and Finance law (1,951)
- Bankruptcy Law (1,397)
- Business law (2,076)
- Constitutional Law (688)
- Contract Law (44)
- Copyright Law (1,415)
- Corporate Law (1,455)
- Criminal Law (1,149)
- Divorce Law (2,187)
- Elder Law (117)
- Employment and Labour Law (1,216)
- Environmental Law (653)
- Estate Planning (691)
- Family Law (1,070)
- General Legal News (225)
- Health Law (1,261)
- Immigration law (883)
- Injury & Accident Law (1,390)
- Insurance (664)
- Intellectual Property (1,357)
- International Law (569)
- Judiciary (562)
- Law Librarians (1,800)
- Law Professors (1,118)
- Law Students (993)
- Legal Ethics (306)
- Legal Marketing (1,086)
- Legal Theory (707)
- Medical malpractice law (1,204)
- Products Liability (847)
- Real Estate & Property Law (938)
- Securities Law (732)
- Seogpst (2)
- Tax Law (1,059)
- Technology & Cyberlaw (1,526)
- World (729)
- Germany (3)
- Writings and Citations (4)
Tag Archives: DIABETES
Diabetes Medicines In DPP-4 Inhibitor Class Might Not Increase Risk Of Inflammatory Bowel Disease (IBD)
But New Medical Study Finds That Januvia, Onglyza, Other Drugs In Class Significantly Increase Risk Of Crohn's Disease (CD) (Posted by Tom Lamb at DrugInjuryWatch.com) Back in March 2018 we wrote this report, "Januvia, Onglyza, And Certain Other … Continue reading
Posted in Health Law
Tagged Bowel, class, DIABETES, Disease, DPP4, IBD , increase, inflammatory, Inhibitor, Medicines, might, Risk
Leave a comment
Diabetes Drugs In DPP-4 Inhibitor Class Associated With Almost Two-Times Increased Risk of Cholangiocarcinoma
Medical Researchers Finding This Rare But Highly Fatal Cancer Call For More Investigation Into This Possible Drug Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) A recent medical study shows that the use of diabetes medicines in the … Continue reading
Posted in Injury & Accident Law
Tagged Almost, Associated, Cholangiocarcinoma, class, DIABETES, DPP4, Drugs, Increased, Inhibitor, Risk, TwoTimes
Leave a comment
Diabetes Drug Tradjenta Associated With Bullous Pemphigoid, A Chronic Blistering Skin Condition
Bullous Pemphigoid (BP) Is An Auto-Immune Skin Disease Which Can Be Fatal, Particularly In Patients Who Are Debilitated (Posted by Tom Lamb at DrugInjuryWatch.com) Three relatively new medical studies add weight to an emerging drug safety issue involving … Continue reading
Posted in Products Liability
Tagged Associated, Blistering, Bullous, Chronic, condition, DIABETES, drug, Pemphigoid, Skin, Tradjenta
Leave a comment
Some Newer Diabetes Drugs Linked To Lower Limb Amputations: "Significantly Increased Risk"
New Study Suggests Possible Drug Class Side Effects Of SGLT-2 Inhibitors Such As Invokana, Jardiance, And Farxiga (Posted by Tom Lamb at DrugInjuryWatch.com) Sodium-glucose cotransporter 2 inhibitors (SGLT-2 inhibitors) are relatively new medicines used to treat Type-2 diabetes. … Continue reading
Posted in Products Liability
Tagged "Significantly, Amputations, DIABETES, Drugs, Increased, Limb, Linked, Lower, Newer, Risk", some
Leave a comment
Logra científica mexicana tortillas de harina que no engordan contra desnutrición, obesidad y diabetes
México ocupa el primer lugar en obesidad infantil a nivel mundial y el segundo en obesidad de adultos, pero la población también sufre desnutrición Una ingeniera de alimentos mexicana desarrolló una peculiar tortilla de harina que no engorda y ayudan … Continue reading
Posted in Intellectual Property
Tagged Científica, Contra, desnutrición, DIABETES, engordan, harina, Logra, mexicana, obesidad, tortillas
Leave a comment